The bureaucratic process of entering the market has been facilitated, to some extent, by the alignment of regulations in Indonesia with regulations applied by other countries in ASEAN under the ASEAN Medical Device Directive (AMDD). In addition, AMDD has brought changes to the classification of health products based on risks that could arise if not handled appropriately. The previous three categories have been replaced with a four-group evaluation system.
Group A – Low risk
Products and medical devices that do not present serious harm if misused, such as cotton, bandages, gauze, sanitary pads, walking sticks and more expensive tools such as wheelchairs or special mattresses.
The products and medical devices included in this group are very broad, and the evaluation focuses primarily on quality and/or durability.
Group B – Low to moderate risk
Products and medical devices that can impact the patient's health in case of malfunction or improper use. Included in this group are hospital electric mattresses, surgical masks and gloves, syringes, hemodialysis fluids and much more.
Clinical trials are not involved in the evaluation process of health instruments. However, a set of requirements must be met for product approval.
Group C – Medium to high risk
Modern tools that may have a serious but not fatal impact on a patient's health if operated without the necessary knowledge. X Rays, ECGs, inpatient monitoring systems, orthopaedic implants, contact lenses, oximeters and many other devices are included in this golongsn.
These products must go through a complex evaluation process, including risk analysis, and the product maker must provide safety facts. However, clinical trials are still not required.
Group D – High risk
Unprofessional use of medical products and devices in this group can be fatal for patients or medical staff.
CT scans, MRIs, cardiac catheters, heart stents, HIV tests, pacemakers, dermal fillers and many other health instruments pose a high risk. Therefore, it takes a long evaluation process before they can be distributed.
In addition, clinical trials, articles published in journals and risk analysis should be conducted and safety facts should be presented to obtain approval smoothly.
Keep in mind that evaluations are charged. The amount depends on the group, and must be paid before taking care of the documents.